NDC 59572-775-01
Reblozyl 75 mg/1
Luspatercept · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Reblozyl is a injection, powder, lyophilized, for solution containing luspatercept at a strength of 75 mg/1. Manufactured by Celgene Corporation.
Key Facts
- Brand Name
- Reblozyl
- Generic Name
- Luspatercept
- NDC Code (Package)
59572-775-01- NDC Code (Product)
59572-775- Manufacturer
- Celgene Corporation
- Strength
- 75 mg/1
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA761136
- Drug Class
- Erythroid Maturation Agent [EPC]
- Marketing Start
- 11/08/2019
Recall History
No Recall HistoryView Full Drug Page
Reblozyl — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.